US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CG Oncology Inc.

24.18

-0.9800-3.90%

Pre-market: 23.21-0.9700-4.01%04:05 EDT

Volume:884.84K

Turnover:21.69M

Market Cap:1.84B

PE:-17.16

High:25.58

Open:24.21

Low:24.08

Close:25.16

Loading ...

Overview Company News Filings

Buy Rating for CG Oncology, Inc.: Strong Potential Amid Market Dynamics and Strategic Positioning

LifeSci Capital Remains a Buy on CG Oncology, Inc. (CGON)

CG Oncology Initiated at Buy by TD Cowen

TD Cowen Initiates CG Oncology at Buy

MT Newswires Live

CG Oncology Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS

CG Oncology, Inc. (CGON) Receives a Buy from TD Cowen

BUZZ-enGene Holdings rises after H.C. Wainwright starts coverage with 'buy'

CG Oncology Closes $238 Million Offering

MT Newswires Live

Press Release: CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

BUZZ-CG Oncology dips after pricing stock offering

BRIEF-CG Oncology Prices Public Offering Of 8 Mln Shares At $28 Per Share

CG Oncology Inc - Prices Public Offering of 8 Mln Shares at $28.00 per Share

THOMSON REUTERS

Press Release: CG Oncology Announces Pricing of Public Offering

CG Oncology Files for Proposed Public Share Offering

MT Newswires Live

BUZZ-CG Oncology falls after unveiling stock offering

BRIEF-CG Oncology Files For Offering Of Up To 7.3 Mln Shares Of Common Stock

CG Oncology Announces Proposed Public Offering

THOMSON REUTERS

CG Oncology Announces Proposed Public Offering

CG Oncology Inc Files for Offering of up to 7.3 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS

CG Oncology files to sell 8M shares of common stock

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CGON/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CGON","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","market":"US","secType":"STK","nameCN":"CG Oncology Inc.","latestPrice":24.18,"timestamp":1747166400000,"preClose":25.16,"halted":0,"volume":884837,"hourTrading":{"tag":"盘前","latestPrice":23.21,"preClose":24.18,"latestTime":"04:05 EDT","volume":1,"amount":23.21,"timestamp":1747209909228},"delay":0,"floatShares":61123015,"shares":76221857,"eps":-1.408697,"marketStatus":"Pre-Mkt","change":-0.98,"latestTime":"05-14 05:41:30 EDT","open":24.21,"high":25.58,"low":24.08,"amount":21686445.257564,"amplitude":0.059618,"askPrice":29.74,"askSize":100,"bidPrice":19.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.408697,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1747229400000},"marketStatusCode":1,"adr":0,"listingDate":1706158800000,"exchange":"NASDAQ","adjPreClose":24.18,"preHourTrading":{"tag":"盘前","latestPrice":23.21,"preClose":24.18,"latestTime":"04:05 EDT","volume":1,"amount":23.21,"timestamp":1747209909228},"postHourTrading":{"tag":"盘后","latestPrice":24.18,"preClose":24.18,"latestTime":"19:22 EDT","volume":20728,"amount":501210.22,"timestamp":1747178550015},"volumeRatio":0.31766208470076834,"impliedVol":0.897,"impliedVolPercentile":0.8514},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CGON\",,,,,undefined,":{"symbol":"CGON","floatShares":61123015,"roa":"-15.02%","roe":"-19.18%","lyrEps":-1.408697,"volumeRatio":0.31766208470076834,"shares":76221857,"dividePrice":0,"high":25.58,"amplitude":0.059618,"preClose":25.16,"low":24.08,"week52Low":14.8,"pbRate":"2.51","psRate":"1618.13","week52High":40.47,"institutionHeld":0,"latestPrice":24.18,"eps":-1.408697,"divideRate":0,"volume":884837,"delay":0,"ttmEps":-1.408697,"open":24.21,"prevYearClose":28.68,"prevWeekClose":23.74,"prevMonthClose":26.94,"prevQuarterClose":24.49,"fiveDayClose":21.7,"twentyDayClose":20.06,"sixtyDayClose":28.52},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CGON\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2502892496","title":"Buy Rating for CG Oncology, Inc.: Strong Potential Amid Market Dynamics and Strategic Positioning","url":"https://stock-news.laohu8.com/highlight/detail?id=2502892496","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502892496?lang=en_us&edition=fundamental","pubTime":"2025-01-11 01:05","pubTimestamp":1736528716,"startTime":"0","endTime":"0","summary":"Andres Y. Maldonado, an analyst from H.C. Wainwright, maintained the Buy rating on CG Oncology, Inc. (CGON – Research Report). The associated price...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-for-cg-oncology-inc-strong-potential-amid-market-dynamics-and-strategic-positioning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-for-cg-oncology-inc-strong-potential-amid-market-dynamics-and-strategic-positioning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","CG"],"gpt_icon":0},{"id":"2502899321","title":"LifeSci Capital Remains a Buy on CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502899321","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502899321?lang=en_us&edition=fundamental","pubTime":"2025-01-10 23:55","pubTimestamp":1736524512,"startTime":"0","endTime":"0","summary":"In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on CG Oncology, Inc. (CGON – Research Report), with a price ta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-cg-oncology-inc-cgon?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-cg-oncology-inc-cgon?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64PRP62.GBP","CG","CGON","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4135","BK4139"],"gpt_icon":0},{"id":"2501787270","title":"CG Oncology Initiated at Buy by TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2501787270","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501787270?lang=en_us&edition=fundamental","pubTime":"2025-01-08 01:14","pubTimestamp":1736270040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CGON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 07, 2025 12:14 ET (17:14 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COWN","IE00B64PRP62.GBP","CG","TD","CGON","IE00BGHQF748.EUR","BK4135","IE00B3QW5Z07.USD","BK4139","BK4585","BK4566","BK4127","BK4207"],"gpt_icon":0},{"id":"2501061182","title":"TD Cowen Initiates CG Oncology at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2501061182","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501061182?lang=en_us&edition=fundamental","pubTime":"2025-01-07 21:12","pubTimestamp":1736255569,"startTime":"0","endTime":"0","summary":"CG Oncology (CGON) has an average rating of buy and mean price target of $69.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IE00B64PRP62.GBP","BK4207","COWN","IE00BGHQF748.EUR","BK4135","CG","BK4566","IE00B3QW5Z07.USD","TD","BK4585","BK4127","CGON"],"gpt_icon":0},{"id":"2501627168","title":"CG Oncology Inc : TD Cowen Initiates Coverage With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2501627168","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501627168?lang=en_us&edition=fundamental","pubTime":"2025-01-07 19:01","pubTimestamp":1736247688,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nFWN3O30QV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2501279258","title":"CG Oncology, Inc. (CGON) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2501279258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501279258?lang=en_us&edition=fundamental","pubTime":"2025-01-07 18:45","pubTimestamp":1736246730,"startTime":"0","endTime":"0","summary":"CG Oncology, Inc. (CGON – Research Report) received a Buy rating and price target from TD Cowen analyst Tyler Van Buren today. The company’s shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cg-oncology-inc-cgon-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cg-oncology-inc-cgon-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TD","BK4135","BK4139","CGON","BK4127","COWN","BK4566","BK4207","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4585","CG","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2493761265","title":"BUZZ-enGene Holdings rises after H.C. Wainwright starts coverage with 'buy'","url":"https://stock-news.laohu8.com/highlight/detail?id=2493761265","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493761265?lang=en_us&edition=fundamental","pubTime":"2024-12-23 23:25","pubTimestamp":1734967521,"startTime":"0","endTime":"0","summary":"BUZZ-enGene Holdings rises after H.C. Wainwright starts coverage with 'buy'** Drug developer enGene Holdings' ENGN.O shares rise 7.2% to $6.24 ** H.C. Wainwright starts coverage with \"buy\" rating and PT of $25 — a ~4x upside to Friday's close ** Brokerage says ENGN's lead drug, detalimogene, can be administered safer and simpler than other gene therapies ** ENGN reported in September that the drug had a complete response rate at any time of 71% in patients with high-risk non-muscle invasive bladder cancer** Brokerage says this is in-line with treatments from CG Oncology CGON.O and Johnson & Johnson JNJ.N** Complete response rate is the percentage of patients in a clinical trial whose cancer completely disappears after treatment.** Brokerage says investors should \"consider the holistic risk/reward profiles of treatments\" rather than focusing solely on the metric** Expects FDA approval for ENGN's drug by 2027 and sales of $868 mln by 2034** All ten brokerages rate stock \"buy\" or higher; ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nL4N3NO0RN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1059921491.USD","LU1894683348.USD","LU1929549753.HKD","BK4585","ENGN","BK4532","LU1914381329.SGD","LU0792757196.USD","IE00BGHQF631.EUR","LU0122379950.USD","LU2602419157.SGD","JNJ","LU0203345920.USD","BK4581","LU1894683264.USD","LU0234572021.USD","IE000M9KFDE8.USD","IE00BSNM7G36.USD","LU1778281490.HKD","LU0289739699.SGD","SG9999002224.SGD","LU0795875086.SGD","LU1244550221.USD","BK4592","LU1221951046.USD","BK4139","LU1732799900.SGD","BK4550","LU1066051811.HKD","LU1066053197.SGD","IE0009355771.USD","LU0320765646.SGD","BK4534","LU0345769631.USD","LU1732800096.USD","LU0882574055.USD","IE0002270589.USD","BK4504","LU1023059063.AUD","BK4007","LU2133065610.SGD","LU1267930813.SGD","LU1280957306.USD","LU0345770993.USD","LU1032466523.USD","LU1074936037.SGD","IE00B3PB1722.GBP","LU0058720904.USD","LU1261432733.SGD","CGON"],"gpt_icon":0},{"id":"2492629191","title":"CG Oncology Closes $238 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2492629191","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492629191?lang=en_us&edition=fundamental","pubTime":"2024-12-17 06:28","pubTimestamp":1734388108,"startTime":"0","endTime":"0","summary":"CG Oncology  said Monday it closed a $238 million public offering of 9.2 million shares at $28 apiece.The offering consists of 8.5 million shares sold by the company, inclusive of 1.2 million shares covered by the underwriters' option to purchase additional shares, and 700,000 shares sold by an existing shareholder, according to a statement.CG Oncology said it did not receive any proceeds from the sale of shares by the selling stockholder.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4135","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","CG","IE00BGHQF748.EUR","CGON"],"gpt_icon":0},{"id":"2492565640","title":"Press Release: CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2492565640","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492565640?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:05","pubTimestamp":1734383100,"startTime":"0","endTime":"0","summary":"CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares. Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, TD Cowen and Stifel, Nicolaus & Company, Incorporated acted as joint book-running managers for the offering. LifeSci Capital LLC acted as lead manager for the offering.This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladd","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023251221.USD","IE0004091025.USD","BK4139","CG","CGON","IE00BGHQF748.EUR","LU0314104364.USD","LU2089283258.USD","LU2089284900.SGD","LU2237443895.HKD","LU2237443465.HKD","LU2237443978.SGD","USA","LU0320765646.SGD","BK4552","IE00BZ1G4Q59.USD","BK4534","BK4135","LU1668664300.SGD","LU0098860793.USD","IE0004086264.USD","LU2271345857.HKD","LU1363072403.SGD","IE00BFXG1179.USD","IE00B19Z3B42.SGD","LU0106831901.USD","LU0267386448.USD","LU2028103732.USD","BK4550","LU2237443549.SGD","LU0158827781.USD","BK4504","IE0002270589.USD","LU0225283273.USD","LU2237443622.USD","LU0158827948.USD","LU1791807156.HKD","BK4588","LU1989772923.USD","BK4127","IE00B3QW5Z07.USD","LU1548497426.USD","LU0106261372.USD","IE00B64PRP62.GBP","IE0034235188.USD","LU2111349929.HKD","IE00BKVL7J92.USD","BK4581","IE00BSNM7G36.USD","BK4585"],"gpt_icon":0},{"id":"2491304350","title":"BUZZ-CG Oncology dips after pricing stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2491304350","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491304350?lang=en_us&edition=fundamental","pubTime":"2024-12-14 02:56","pubTimestamp":1734116178,"startTime":"0","endTime":"0","summary":"** Shares of cancer drug developer CG Oncology CGON.O fall 0.5% to $28.72** CGON late Thursday priced its stock offering of 8 mln shares at $28/shr** Offering priced at a 3% discount to stock's last close** Investment firm ORI Capital parted ways with 700,000 shares while CGON sold 7.3 mln shares in the stock offering ** Gross proceeds of roughly $204.4 mln from the offering for CGON, which will use it to fund the development of its experimental immunotherapy** Morgan Stanley, Goldman Sachs, TD Cowen and Stifel were the joint book-running managers for the offering** CGON went public in New York in January after raising $380 mln in its IPO at $19 offer price** As of last close, CGON shares up 52% since debut on Jan. 25  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nL4N3NE0UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4552","IE0034235188.USD","LU2237443465.HKD","LU2357305700.SGD","LU2089284900.SGD","CGON","LU0267386448.USD","IE0002270589.USD","LU0158827948.USD","LU0098860793.USD","LU0158827781.USD","BK4127","LU1162221912.USD","LU2237443382.USD","LU1989772923.USD","LU1074936037.SGD","LU1791807156.HKD","BK4588","LU0006306889.USD","IE00BZ1G4Q59.USD","LU2237443549.SGD","IE00B19Z3581.USD","IE0004086264.USD","BK4550","LU2028103732.USD","LU2111349929.HKD","BK4504","LU0225283273.USD","BK4585","LU1363072403.SGD","BK4139","LU2089283258.USD","LU2271345857.HKD","LU0106831901.USD","LU0320765646.SGD","IE00BSNM7G36.USD","SF","LU0971096721.USD","LU1548497426.USD","LU1989772840.SGD","LU2023251221.USD","LU0314104364.USD","LU2237443978.SGD","BK4581","LU1720051108.HKD","LU1668664300.SGD","LU2237443622.USD","IE00BKVL7J92.USD","BK4534","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2491360474","title":"BRIEF-CG Oncology Prices Public Offering Of 8 Mln Shares At $28 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2491360474","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491360474?lang=en_us&edition=fundamental","pubTime":"2024-12-13 09:20","pubTimestamp":1734052837,"startTime":"0","endTime":"0","summary":"BRIEF-CG Oncology Prices Public Offering Of 8 Mln Shares At $28 Per ShareDec 12 (Reuters) - CG Oncology Inc CGON.O:PRICING OF PUBLIC OFFERINGPRICES PUBLIC OFFERING OF 8 MILLION SHARES AT $28.00 PER SH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nTUA7XD4X1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2491360119","title":"CG Oncology Inc - Prices Public Offering of 8 Mln Shares at $28.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2491360119","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491360119?lang=en_us&edition=fundamental","pubTime":"2024-12-13 09:19","pubTimestamp":1734052760,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nTUA7XD4X1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2491466360","title":"Press Release: CG Oncology Announces Pricing of Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2491466360","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491466360?lang=en_us&edition=fundamental","pubTime":"2024-12-13 09:19","pubTimestamp":1734052740,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Dec. 12, 2024  -- CG Oncology, Inc. , a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer, today announced the pricing of its public offering of 8,000,000 shares of its common stock, 7,300,000 of which are being offered by CG Oncology and 700,000 of which are being offered by an existing stockholder of CG Oncology, each at a public offering price of $28.00 per share. The gross proceeds to CG Oncology from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $204.4 million. CG Oncology will not receive proceeds from the sale of shares of its common stock by the selling stockholder. The offering is expected to close on December 16, 2024, subject to the satisfaction of customary closing conditions. In addition, CG Oncology has granted the underwriters a 30-day option to purchase up","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","IE00B64PRP62.GBP","LU0225283273.USD","LU2237443622.USD","LU2237443895.HKD","LU2111349929.HKD","IE00BKVL7J92.USD","LU2089284900.SGD","IE00BZ1G4Q59.USD","LU1668664300.SGD","IE00BGHQF748.EUR","LU0971096721.USD","LU1074936037.SGD","BK4504","LU1720051108.HKD","BK4581","LU0098860793.USD","LU1162221912.USD","CGON","LU0158827948.USD","LU1720051017.SGD","LU1989772840.SGD","LU0320765646.SGD","BK4588","LU1791807156.HKD","IE00BFXG1179.USD","LU0106831901.USD","IE0004086264.USD","IE00B19Z3581.USD","BK4516","IE00BSNM7G36.USD","LU2023251221.USD","LU2237443382.USD","BK4550","LU0158827781.USD","LU2237443978.SGD","LU2357305700.SGD","LU1989772923.USD","BK4585","IE0004091025.USD","LU0267386448.USD","BK4534","USA","LU2271345857.HKD","BK4135","LU2089283258.USD","LU0314104364.USD","LU1548497426.USD","LU2237443549.SGD","IE0002270589.USD"],"gpt_icon":0},{"id":"2490785587","title":"CG Oncology Files for Proposed Public Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2490785587","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490785587?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:06","pubTimestamp":1733918794,"startTime":"0","endTime":"0","summary":"CG Oncology  said Wednesday that it has filed a registration statement for a proposed underwritten public offering of 7.3 million shares of its common stock.The company said it plans to grant the underwriters a 30-day option to buy up to an additional 1.2 million shares of its common stock.The company added that an existing stockholder also plans to sell 700,000 shares of common stock in the proposed offering.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CG","IE00BGHQF748.EUR","BK4135","IE00B64PRP62.GBP","BK4139","CGON","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2490853596","title":"BUZZ-CG Oncology falls after unveiling stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2490853596","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490853596?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:57","pubTimestamp":1733918269,"startTime":"0","endTime":"0","summary":"** Shares of cancer drug developer CG Oncology    fall 4.8% to $32.09 premarket   ** CGON unveils proposed public offering wherein the late-stage drug developer along with an existing shareholder plans to sell shares   ** Co is offering 7.3 mln shares, while investment firm ORI Capital is selling 700,000 shares in the proposed offering   ** CGON's experimental immunotherapy has shown promise in bladder cancer, researchers reported last week      ** Co plans to use the proceeds to fund the development of its experimental immunotherapy   ** Morgan Stanley, Goldman Sachs, TD Cowen and Stifel are the joint book-running managers for the offering    ** Co has 67.6 mln outstanding shares and $2.28 bln market capitalization - LSEG data    ** CGON debuted on the Nasdaq in January after an upsized $380 mln offering at $19 IPO price      ** As of last close, CGON shares up 77.4% since debut on Jan. 25 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU1668664300.SGD","LU1989772840.SGD","BK4588","LU0225283273.USD","LU0267386448.USD","LU2023251221.USD","CG","LU2089284900.SGD","LU2357305700.SGD","LU0158827948.USD","LU2028103732.USD","IE00BZ1G4Q59.USD","BK4504","BK4139","BK4585","BK4127","LU0106261372.USD","BK4516","LU0320765646.SGD","LU0158827781.USD","LU1162221912.USD","LU1363072403.SGD","IE00BKVL7J92.USD","LU1989772923.USD","LU0314104364.USD","IE00B64PRP62.GBP","LU0971096721.USD","LU2111349929.HKD","LU0106831901.USD","LU0098860793.USD","CGON","IE00B3QW5Z07.USD","LU2271345857.HKD","LU2089283258.USD","LU1720051108.HKD","LU0006306889.USD","LU1074936037.SGD","BK4534","BK4581","IE00BGHQF748.EUR","BK4135","LU1548497426.USD"],"gpt_icon":0},{"id":"2490300268","title":"BRIEF-CG Oncology Files For Offering Of Up To 7.3 Mln Shares Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2490300268","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490300268?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:34","pubTimestamp":1733916890,"startTime":"0","endTime":"0","summary":"BRIEF-CG Oncology Files For Offering Of Up To 7.3 Mln Shares Of Common StockDec 11  - CG Oncology Inc CGON.O:CG ONCOLOGY INC FILES FOR OFFERING OF UP TO 7.3 MILLION SHARES OF COMMON STOCK - SEC FILINGCG ONCOLOGY INC SAYS IN ADDITION, SELLING STOCKHOLDER OFFERING 700,000 SHARES OF COMMON STOCKFurther company coverage: CGON.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0Q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","BK4139"],"gpt_icon":0},{"id":"2490837742","title":"CG Oncology Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2490837742","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490837742?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:17","pubTimestamp":1733915843,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nTUA8YT1PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2490308838","title":"CG Oncology Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2490308838","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490308838?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:17","pubTimestamp":1733915820,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Dec.  11, 2024  (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bla","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/11/2995211/0/en/CG-Oncology-Announces-Proposed-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","LU2089283258.USD","BK4588","LU0314104364.USD","LU1720051017.SGD","LU2271345857.HKD","LU2028103732.USD","BK4534","LU0267386448.USD","IE00B3QW5Z07.USD","BK4581","IE00BZ1G4Q59.USD","LU2357305700.SGD","BK4504","LU0158827781.USD","LU0320765646.SGD","LU2089284900.SGD","LU0106831901.USD","BK4135","LU1668664300.SGD","LU2111349929.HKD","LU0106261372.USD","LU1074936037.SGD","LU1363072403.SGD","CGON","BK4139","LU0971096721.USD","LU0006306889.USD","IE00B64PRP62.GBP","BK4127","LU0158827948.USD","LU2023251221.USD","BK4585","LU1162221912.USD","LU1548497426.USD","IE00BGHQF748.EUR","LU0225283273.USD","BK4516","CG","LU1989772923.USD","LU1720051108.HKD","USA","LU0098860793.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2490837444","title":"CG Oncology Inc Files for Offering of up to 7.3 Mln Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2490837444","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490837444?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:13","pubTimestamp":1733915589,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC0Q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CGON"],"gpt_icon":0},{"id":"2490783085","title":"CG Oncology files to sell 8M shares of common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2490783085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490783085?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:10","pubTimestamp":1733915417,"startTime":"0","endTime":"0","summary":"The company is offering 7.3M shares of common stock. Charming Jade Limited, the selling stockholder identified in this prospectus, is offering an a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cg-oncology-files-to-sell-8m-shares-of-common-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cg-oncology-files-to-sell-8m-shares-of-common-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CGON","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","CG","IE00B64PRP62.GBP","BK4135"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":119,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CGON\",params:#limit:5,,,undefined,":[{"date":"2025-05-13","symbol":"CGON","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1747123200000,"name":null,"time":"Pre-Market","dateTimestamp":1747108800000,"actualEps":null},{"market":"US","date":"2025-03-28","symbol":"CGON","fiscalQuarterEnding":"2024/12","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743134400000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2024-11-12","symbol":"CGON","fiscalQuarterEnding":"2024/09","expectedEps":-0.42,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CGON\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CGON\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1,"buy":0.8,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":10,"updateTime":1746244800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CGON\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CGON","date":"2025-05-12","current":-20.553469,"percent":0.934426,"low":-77.942097,"twenty":-49.99741,"median":-39.070966,"eighty":-28.006384,"high":-13.496527,"avg":-39.876482,"sd":14.138363,"marketCap":1809506885},"quantilePoints":[{"date":"2024-01-26","current":-62.124194,"twenty":-62.124194,"median":-62.124194,"eighty":-62.124194,"marketCap":2539823423},{"date":"2024-02-02","current":-61.712969,"twenty":-61.712969,"median":-60.379514,"eighty":-59.355029,"marketCap":2523011292},{"date":"2024-02-09","current":-63.452965,"twenty":-62.124194,"median":-60.590915,"eighty":-59.355029,"marketCap":2594147579},{"date":"2024-02-16","current":-77.177799,"twenty":-70.608092,"median":-61.918582,"eighty":-60.168112,"marketCap":3155259972},{"date":"2024-02-23","current":-75.080046,"twenty":-72.448911,"median":-64.672589,"eighty":-60.20714,"marketCap":3069497532},{"date":"2024-03-01","current":-72.705845,"twenty":-73.870179,"median":-70.608092,"eighty":-60.516111,"marketCap":2972433066},{"date":"2024-03-08","current":-64.818944,"twenty":-72.891228,"median":-69.827533,"eighty":-60.799064,"marketCap":2649992888},{"date":"2024-03-15","current":-60.493345,"twenty":-72.302556,"median":-67.469593,"eighty":-60.20714,"marketCap":2473149409},{"date":"2024-03-22","current":-66.867912,"twenty":-72.162706,"median":-65.355579,"eighty":-60.438055,"marketCap":2733760852},{"date":"2024-03-28","current":-56.207672,"twenty":-71.967566,"median":-64.762028,"eighty":-59.842879,"marketCap":2732086332},{"date":"2024-04-05","current":-51.752186,"twenty":-71.648838,"median":-63.50175,"eighty":-58.14191,"marketCap":2515518513},{"date":"2024-04-12","current":-54.631116,"twenty":-71.284577,"median":-62.382039,"eighty":-56.136384,"marketCap":2655454642},{"date":"2024-04-19","current":-48.420853,"twenty":-71.001624,"median":-61.712969,"eighty":-54.576279,"marketCap":2353592420},{"date":"2024-04-26","current":-49.627262,"twenty":-70.73168,"median":-60.54213,"eighty":-53.208102,"marketCap":2412232322},{"date":"2024-05-03","current":-54.151294,"twenty":-70.286112,"median":-60.183337,"eighty":-53.600185,"marketCap":2632131954},{"date":"2024-05-10","current":-35.176138,"twenty":-69.778748,"median":-59.371617,"eighty":-52.278619,"marketCap":2000537303},{"date":"2024-05-17","current":-36.289307,"twenty":-68.393255,"median":-58.232975,"eighty":-49.860318,"marketCap":2063845445},{"date":"2024-05-24","current":-35.140985,"twenty":-67.52163,"median":-57.330453,"eighty":-49.032283,"marketCap":1998538098},{"date":"2024-05-31","current":-40.179539,"twenty":-67.228921,"median":-56.207672,"eighty":-47.173317,"marketCap":2285090743},{"date":"2024-06-07","current":-40.894311,"twenty":-66.477632,"median":-55.878652,"eighty":-42.192617,"marketCap":2325741235},{"date":"2024-06-14","current":-40.788853,"twenty":-65.885708,"median":-55.522213,"eighty":-41.278647,"marketCap":2319743621},{"date":"2024-06-21","current":-37.625109,"twenty":-65.85969,"median":-54.631116,"eighty":-40.788853,"marketCap":2139815216},{"date":"2024-06-28","current":-35.445642,"twenty":-65.443392,"median":-54.494024,"eighty":-40.683395,"marketCap":2015864537},{"date":"2024-07-05","current":-36.125261,"twenty":-64.796178,"median":-54.151294,"eighty":-39.560851,"marketCap":2054515824},{"date":"2024-07-12","current":-40.378738,"twenty":-64.675841,"median":-53.136814,"eighty":-38.206301,"marketCap":2296419569},{"date":"2024-07-15","current":-41.491907,"twenty":-64.64657,"median":-52.780375,"eighty":-38.236766,"marketCap":2359727711},{"date":"2024-08-02","current":-39.652248,"twenty":-64.6173,"median":-52.752957,"eighty":-38.267232,"marketCap":2255102676},{"date":"2024-08-09","current":-38.949194,"twenty":-63.924553,"median":-51.752186,"eighty":-38.000071,"marketCap":2215118586},{"date":"2024-08-16","current":-40.572681,"twenty":-63.472479,"median":-49.956283,"eighty":-38.105529,"marketCap":2307449488},{"date":"2024-08-23","current":-42.377221,"twenty":-62.965116,"median":-49.723226,"eighty":-38.189896,"marketCap":2410077328},{"date":"2024-08-30","current":-43.2618,"twenty":-62.33047,"median":-48.934948,"eighty":-38.276606,"marketCap":2460385093},{"date":"2024-09-06","current":-44.299706,"twenty":-62.063778,"median":-48.270052,"eighty":-38.375033,"marketCap":2519412871},{"date":"2024-09-13","current":-41.079839,"twenty":-61.869081,"median":-45.980618,"eighty":-38.588613,"marketCap":2336292606},{"date":"2024-09-20","current":-46.127835,"twenty":-61.368222,"median":-44.806865,"eighty":-38.861791,"marketCap":2623382252},{"date":"2024-09-27","current":-43.379744,"twenty":-60.747027,"median":-44.736098,"eighty":-39.046612,"marketCap":2467092795},{"date":"2024-10-04","current":-42.412604,"twenty":-60.551887,"median":-44.517902,"eighty":-39.324835,"marketCap":2412089639},{"date":"2024-10-11","current":-40.667036,"twenty":-60.382766,"median":-44.458898,"eighty":-39.52313,"marketCap":2312815649},{"date":"2024-10-18","current":-43.356155,"twenty":-60.203473,"median":-44.063818,"eighty":-39.574912,"marketCap":2465751255},{"date":"2024-10-25","current":-42.990529,"twenty":-60.177247,"median":-43.698192,"eighty":-39.657154,"marketCap":2444957379},{"date":"2024-10-31","current":-42.837202,"twenty":-60.01213,"median":-43.662809,"eighty":-39.673778,"marketCap":2436237366},{"date":"2024-11-08","current":-46.068863,"twenty":-59.381569,"median":-43.651015,"eighty":-39.804577,"marketCap":2620028401},{"date":"2024-11-15","current":-32.980568,"twenty":-59.208121,"median":-43.63922,"eighty":-39.654701,"marketCap":2400853462},{"date":"2024-11-22","current":-30.044833,"twenty":-58.542987,"median":-43.538968,"eighty":-38.997903,"marketCap":2187143689},{"date":"2024-11-29","current":-32.283796,"twenty":-58.232975,"median":-43.444613,"eighty":-38.328163,"marketCap":2350131206},{"date":"2024-12-06","current":-31.17825,"twenty":-58.005312,"median":-43.379744,"eighty":-38.000071,"marketCap":2269651893},{"date":"2024-12-13","current":-26.821099,"twenty":-57.745125,"median":-43.279491,"eighty":-37.543086,"marketCap":1952468717},{"date":"2024-12-20","current":-26.031423,"twenty":-56.915781,"median":-43.120267,"eighty":-36.394765,"marketCap":1894983493},{"date":"2024-12-27","current":-27.044066,"twenty":-56.349294,"median":-43.061296,"eighty":-36.125261,"marketCap":1968699839},{"date":"2025-01-03","current":-26.914002,"twenty":-56.207672,"median":-43.037707,"eighty":-35.33784,"marketCap":1959231684},{"date":"2025-01-10","current":-28.298257,"twenty":-56.136384,"median":-42.978735,"eighty":-34.953504,"marketCap":2059999900},{"date":"2025-01-17","current":-27.034776,"twenty":-55.969133,"median":-42.872585,"eighty":-33.374909,"marketCap":1968023542},{"date":"2025-01-24","current":-32.158189,"twenty":-55.840266,"median":-42.689773,"eighty":-32.852839,"marketCap":2340987506},{"date":"2025-01-31","current":-31.530712,"twenty":-55.653821,"median":-42.565931,"eighty":-32.283796,"marketCap":2295309701},{"date":"2025-02-07","current":-31.405216,"twenty":-55.437216,"median":-42.394913,"eighty":-32.036945,"marketCap":2286174140},{"date":"2025-02-14","current":-29.805151,"twenty":-55.004006,"median":-42.206678,"eighty":-31.677123,"marketCap":2169695737},{"date":"2025-02-21","current":-29.512328,"twenty":-54.631116,"median":-41.999801,"eighty":-31.530712,"marketCap":2148379428},{"date":"2025-02-28","current":-25.768383,"twenty":-54.494024,"median":-41.775708,"eighty":-31.373843,"marketCap":1875835192},{"date":"2025-03-07","current":-28.226,"twenty":-54.39406,"median":-41.609082,"eighty":-31.094637,"marketCap":2054739928},{"date":"2025-03-14","current":-27.138374,"twenty":-54.151294,"median":-41.292708,"eighty":-30.560445,"marketCap":1975565066},{"date":"2025-03-21","current":-29.020804,"twenty":-53.671473,"median":-41.068045,"eighty":-30.21301,"marketCap":2112598481},{"date":"2025-03-28","current":-28.173711,"twenty":-53.493253,"median":-40.922206,"eighty":-29.826066,"marketCap":2050933444},{"date":"2025-04-04","current":-16.223536,"twenty":-52.780375,"median":-40.788853,"eighty":-29.478125,"marketCap":1428303862},{"date":"2025-04-11","current":-15.26259,"twenty":-52.725539,"median":-40.592885,"eighty":-29.073094,"marketCap":1343703153},{"date":"2025-04-17","current":-17.504797,"twenty":-52.648767,"median":-40.36956,"eighty":-28.807616,"marketCap":1541104808},{"date":"2025-04-25","current":-18.630229,"twenty":-51.927664,"median":-39.710836,"eighty":-28.715432,"marketCap":1640186719},{"date":"2025-05-02","current":-24.014988,"twenty":-51.631545,"median":-39.587801,"eighty":-28.276198,"marketCap":2114255557},{"date":"2025-05-09","current":-20.891121,"twenty":-50.318205,"median":-39.192738,"eighty":-28.046644,"marketCap":1839233409},{"date":"2025-05-12","current":-20.553469,"twenty":-49.99741,"median":-39.070966,"eighty":-28.006384,"marketCap":1809506885}],"updateTime":1747193582913}}}